Supplement to reduce radiation side effects in cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests an oral supplement (sodium-copper-chlorophyllin) to see if it can reduce long-term side effects from radiation therapy in women with locally advanced cervical cancer. It may help protect the rectum and bladder from radiation damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older with a specific type of cervical cancer (squamous cell or adenocarcinoma) that has spread locally but not to distant organs.
- You are scheduled for radiation therapy with or without chemotherapy and brachytherapy (a type of internal radiation).
- Your radiation dose to the rectum or bladder is expected to be higher than normal safe limits.
- Your blood counts, kidney function, and liver function must be within certain healthy ranges (hemoglobin ≥8, white blood cells ≥1,500, platelets ≥100,000, creatinine clearance ≥50, etc.).
- You can swallow pills, follow study instructions, and give written consent.
- You are not HIV positive, do not have a bleeding disorder, are not on blood thinners, and are not in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking chlorophyllin can reduce mouth sores caused by total body radiation given before a stem cell transplant. The goal is to make the treatment easier to tolerate.
This trial tests a way to reduce blood-related side effects from chemoradiation for locally advanced cervical cancer. It aims to make treatment safer and more tolerable.
This trial studies whether taking curcumin (from turmeric) during palliative radiation can improve outcomes for people with advanced cervical cancer. It’s meant for patients who are receiving radiation for symptom relief without chemotherapy.
This trial compares two chemotherapy drugs (cisplatin vs. gemcitabine) given together with radiation therapy for locally advanced cervical cancer. The goal is to see which is more effective and has fewer side effects.
This trial tests a combination of pelvic chemoradiation (chemotherapy and radiation) with a special type of brachytherapy (internal radiation) that adjusts the dose during treatment for locally advanced cervical cancer. It aims to improve tumor control while keeping side effects manageable.
This trial tests a shorter course of radiation therapy (fewer, higher-dose sessions) for women in Uganda with locally advanced cervical cancer. The goal is to see if this approach works as well as or better than standard radiation while reducing treatment time.
Hear when a new Uterine Cervical Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.